Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.
1 other identifier
interventional
100
1 country
2
Brief Summary
Open inguinal hernia repair is one of the most common surgical procedures. Despite the fact that different of anesthetic procedures are proposed as alternatives to spinal anesthesia, the combination of spinal anesthesia with open inguinal hernia repair is preferred from both surgeons and patients. One disadvantage of this combination is the high incidence of post-surgery urinary retention, especially in men above 50 years old. This complication is partially attribute to overstimulation of the a1 adrenergic receivers of the bladder and the prostate. Preoperative administration of elective a1 blockers could inhibit this effect without side effects, since this drugs don't have systemic effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Feb 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2019
CompletedFirst Posted
Study publicly available on registry
June 6, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2021
CompletedNovember 26, 2021
November 1, 2021
1.7 years
May 31, 2019
November 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of urinary retention
inability to voluntarily void urine up to 8 hours post surgery
8 hours post surgery
Secondary Outcomes (6)
Prostate related Symptoms
Baseline
Scrotal hernia Repair
Baseline, Inta-operative
Duration of Surgery
Duration of Surgical procedure
Use of opioids
24 hours
Iv fluid administration
24 hours
- +1 more secondary outcomes
Study Arms (2)
Tamsulosin group
ACTIVE COMPARATORadministration of 0,4mg of tamsulosin 24 hours before surgery and 0,4mg 6 hours before surgery
Placebo group
PLACEBO COMPARATORadministration of placebo 24 and 6 hours before surgery
Interventions
Eligibility Criteria
You may qualify if:
- unilateral inguinal hernia
You may not qualify if:
- ASA score \>3
- hypotension
- prostatic hypertrophy
- complicated inguinal hernia
- neurological diseases
- inguinal hernia repair under general or local anaesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Georgios Koukoulislead
- University of Thessalycollaborator
Study Sites (2)
University General Hospital of Larissa
Larissa, 41110, Greece
General Hospital Of Larissa
Larissa, 41221, Greece
Related Publications (3)
Clancy C, Coffey JC, O'Riordain MG, Burke JP. A meta-analysis of the efficacy of prophylactic alpha-blockade for the prevention of urinary retention following primary unilateral inguinal hernia repair. Am J Surg. 2018 Aug;216(2):337-341. doi: 10.1016/j.amjsurg.2017.02.017. Epub 2017 Mar 14.
PMID: 28341140BACKGROUNDBasheer A, Alsaidi M, Schultz L, Chedid M, Abdulhak M, Seyfried D. Preventive effect of tamsulosin on postoperative urinary retention in neurosurgical patients. Surg Neurol Int. 2017 May 10;8:75. doi: 10.4103/sni.sni_5_17. eCollection 2017.
PMID: 28584678BACKGROUNDShaw MK, Pahari H. The role of peri-operative use of alpha-blocker in preventing lower urinary tract symptoms in high risk patients of urinary retention undergoing inguinal hernia repair in males above 50 years. J Indian Med Assoc. 2014 Jan;112(1):13-4, 16.
PMID: 25935942BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Konstantinos Tepetes, MD, PHD
University Hospital of Larisa and Medical School, University of Thessaly
- PRINCIPAL INVESTIGATOR
Georgios D Koukoulis, MD, PhD
General Hospital of Larissa
- PRINCIPAL INVESTIGATOR
Konstantinos Mpouliaris, MD
General Hospital of Larissa
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- General Surgery Consultant
Study Record Dates
First Submitted
May 31, 2019
First Posted
June 6, 2019
Study Start
February 1, 2020
Primary Completion
October 1, 2021
Study Completion
October 30, 2021
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share